ES2192577T3 - Composicion de acetato de almidon con propiedades modificables y procedimiento para la preparacion y utilizacion de dicha composicion. - Google Patents

Composicion de acetato de almidon con propiedades modificables y procedimiento para la preparacion y utilizacion de dicha composicion.

Info

Publication number
ES2192577T3
ES2192577T3 ES95920923T ES95920923T ES2192577T3 ES 2192577 T3 ES2192577 T3 ES 2192577T3 ES 95920923 T ES95920923 T ES 95920923T ES 95920923 T ES95920923 T ES 95920923T ES 2192577 T3 ES2192577 T3 ES 2192577T3
Authority
ES
Spain
Prior art keywords
composition
almidon
acetate
modificable
properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95920923T
Other languages
English (en)
Inventor
Timo Petteri Paronen
Soili Hellevi Peltonen
Arto Olavi Urtti
Leena Johanna Nakari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polymer Corex Kuopio Oy Ltd
Original Assignee
Polymer Corex Kuopio Oy Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polymer Corex Kuopio Oy Ltd filed Critical Polymer Corex Kuopio Oy Ltd
Application granted granted Critical
Publication of ES2192577T3 publication Critical patent/ES2192577T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/02—Esters
    • C08B31/04—Esters of organic acids, e.g. alkenyl-succinated starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/04—Starch derivatives, e.g. crosslinked derivatives
    • C08L3/06—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Confectionery (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cereal-Derived Products (AREA)
  • Fertilizers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN NUEVO TIPO DE COMPOSICION CON PROPIEDADES MODIFICABLES Y APROPIADA PARA LA LIBERACION CONTROLADA DE INGREDIENTES ACTIVOS DE USO INDUSTRIAL. LA COMPOSICION CONTIENE UN INGREDIENTE ACTIVO Y ACETATO DE ALMIDON EN FORMA DE UN COMPACTO. LA INVENCION SE REFIERE MAS ESPECIFICAMENTE A INGREDIENTES ACTIVOS TALES COMO FORMAS SOLIDAS DE DOSIFICACION DE MEDICAMENTOS, ESPECIALMENTE COMPACTOS Y PASTILLAS. EN ESTOS COMPACTOS SE EMPLEA ACETATO DE ALMIDON CON DISTINTOS GRADOS DE SUSTITUCION. EL ACETATO DE ALMIDON HACE QUE EL PROCESO SEA INDUSTRIALMENTE FACTIBLE CON UNA BUENA FLUENCIA Y FACILITA LA FORMACION DE PASTILLAS SOLIDAS. EL ACETATO DE ALMIDON PERMITE LA LIBERACION CONTROLADA DEL INGREDIENTE ACTIVO. LA INVENCION TAMBIEN SE REFIERE A UN METODO PARA LA PREPARACION DE LA COMPOSICION ASI COMO SU USO.
ES95920923T 1994-06-07 1995-06-07 Composicion de acetato de almidon con propiedades modificables y procedimiento para la preparacion y utilizacion de dicha composicion. Expired - Lifetime ES2192577T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI942686A FI942686A0 (fi) 1994-06-07 1994-06-07 Komposition innehaollande staerkelseacetat med varierande egenskaper, foerfarande foer dess framstaellning och anvaendning

Publications (1)

Publication Number Publication Date
ES2192577T3 true ES2192577T3 (es) 2003-10-16

Family

ID=8540869

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95920923T Expired - Lifetime ES2192577T3 (es) 1994-06-07 1995-06-07 Composicion de acetato de almidon con propiedades modificables y procedimiento para la preparacion y utilizacion de dicha composicion.

Country Status (13)

Country Link
US (1) US5667803A (es)
EP (1) EP0806942B1 (es)
JP (1) JPH10502056A (es)
AT (1) ATE237315T1 (es)
AU (1) AU712839B2 (es)
CA (1) CA2190181A1 (es)
DE (1) DE69530421T2 (es)
DK (1) DK0806942T3 (es)
ES (1) ES2192577T3 (es)
FI (2) FI942686A0 (es)
HU (1) HUT75773A (es)
PT (1) PT806942E (es)
WO (1) WO1995033450A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656292A (en) * 1994-06-07 1997-08-12 Alko Group Ltd. Composition for pH dependent controlled release of active ingredients and methods for producing it
FI107386B (fi) * 1996-12-31 2001-07-31 Valtion Teknillinen Menetelmä tärkkelysesterien valmistamiseksi
US20040185170A1 (en) * 2003-03-21 2004-09-23 Shubha Chungi Method for coating drug-containing particles and formulations and dosage units formed therefrom
FI117757B (fi) * 2004-12-08 2007-02-15 M Real Oyj Tärkkelysasetaattikomposiitit, menetelmä niiden valmistamiseksi ja käyttö paperin ja kartongin valmistuksessa
US7957507B2 (en) 2005-02-28 2011-06-07 Cadman Patrick F Method and apparatus for modulating a radiation beam
US8232535B2 (en) 2005-05-10 2012-07-31 Tomotherapy Incorporated System and method of treating a patient with radiation therapy
JP2009506800A (ja) 2005-07-22 2009-02-19 トモセラピー・インコーポレーテッド 線量デリバリを予測する方法およびシステム
WO2007014106A2 (en) 2005-07-22 2007-02-01 Tomotherapy Incorporated System and method of delivering radiation therapy to a moving region of interest
US7574251B2 (en) 2005-07-22 2009-08-11 Tomotherapy Incorporated Method and system for adapting a radiation therapy treatment plan based on a biological model
US7839972B2 (en) 2005-07-22 2010-11-23 Tomotherapy Incorporated System and method of evaluating dose delivered by a radiation therapy system
US7567694B2 (en) 2005-07-22 2009-07-28 Tomotherapy Incorporated Method of placing constraints on a deformation map and system for implementing same
US8442287B2 (en) * 2005-07-22 2013-05-14 Tomotherapy Incorporated Method and system for evaluating quality assurance criteria in delivery of a treatment plan
JP5060476B2 (ja) 2005-07-22 2012-10-31 トモセラピー・インコーポレーテッド 放射線療法を受けている患者の呼吸位相を検出するシステムおよび方法
US7639854B2 (en) 2005-07-22 2009-12-29 Tomotherapy Incorporated Method and system for processing data relating to a radiation therapy treatment plan
CN101268474A (zh) 2005-07-22 2008-09-17 断层放疗公司 用于估算实施剂量的方法和系统
WO2007014091A2 (en) 2005-07-22 2007-02-01 Tomotherapy Incorporated System and method of generating contour structures using a dose volume histogram
US7773788B2 (en) 2005-07-22 2010-08-10 Tomotherapy Incorporated Method and system for evaluating quality assurance criteria in delivery of a treatment plan
EP3175886B1 (en) 2005-07-23 2018-06-27 TomoTherapy, Inc. Radiation therapy imaging and delivery utilizing coordinated motion of gantry and couch
WO2007055329A1 (ja) * 2005-11-11 2007-05-18 Asahi Kasei Chemicals Corporation 徐放性固形製剤
FR2937040B1 (fr) * 2008-10-13 2012-07-27 Roquette Freres Compositions thermoplastiques ou elastomeriques a base d'esters d'une matiere amylacee et procede de preparation de telles compositions
EP2386297A1 (en) 2010-04-28 2011-11-16 Roquette Frères Indigestible polymer: starch acetate -based film coatings for colon targeting
CN105027227B (zh) 2013-02-26 2017-09-08 安科锐公司 电磁致动的多叶准直器
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CA3050150C (en) * 2017-01-23 2021-07-06 CannTab Therapeutics Limited Immediate release cannabidiol formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE272999C (es) *
NL273273A (es) * 1961-01-06
GB1216873A (en) * 1967-06-16 1970-12-23 Staley Mfg Co A E Compacted starch; its preparation and use
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US3795670A (en) * 1973-03-05 1974-03-05 Us Agriculture Process for making starch triacetates
DD272999A1 (de) * 1988-06-20 1989-11-01 Univ Halle Wittenberg Verfahren zur herstellung ueberzogener arzneiformen
DE4123001A1 (de) * 1991-07-11 1993-01-14 Laevosan Gmbh & Co Kg Pharmazeutische zusammensetzung fuer die peritonealdialyse
DE4123000A1 (de) * 1991-07-11 1993-01-14 Laevosan Gmbh & Co Kg Verfahren zur herstellung von staerkeestern fuer klinische, insbesondere parenterale anwendung
US5205863A (en) * 1991-11-14 1993-04-27 International Communications & Energy Agricultural biodegradable plastics
JPH07505433A (ja) * 1992-03-31 1995-06-15 ノボン・インターナショナル・インコーポレーテッド 生分解性ポリマー組成物

Also Published As

Publication number Publication date
WO1995033450A1 (en) 1995-12-14
ATE237315T1 (de) 2003-05-15
EP0806942A1 (en) 1997-11-19
DE69530421D1 (de) 2003-05-22
FI964770L (fi) 1997-01-29
JPH10502056A (ja) 1998-02-24
EP0806942B1 (en) 2003-04-16
HU9603351D0 (en) 1997-02-28
HUT75773A (en) 1997-05-28
US5667803A (en) 1997-09-16
CA2190181A1 (en) 1995-12-14
DK0806942T3 (da) 2003-08-04
AU2618295A (en) 1996-01-04
PT806942E (pt) 2003-07-31
FI942686A0 (fi) 1994-06-07
DE69530421T2 (de) 2003-10-30
FI964770A0 (fi) 1996-11-29
AU712839B2 (en) 1999-11-18
FI113273B (fi) 2004-03-31

Similar Documents

Publication Publication Date Title
TW200510375A (en) New compounds
GT199900203A (es) Composiciones de celecoxib.
UY28213A1 (es) Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
MXPA04009163A (es) Nuevos compuestos.
AR246012A1 (es) Metodo para producir tabletas de colestiramina directamente comprimidas que poseen un revestimiento libre de solventes.
IL189927A0 (en) Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
ES2158988T3 (es) Composiciones de aerosol.
PA8608201A1 (es) Compuestos de indazol 3,5-disustituidos, composiciones farmaceuticas y metodos para intervenir en o inhibir la proliferacion celular
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
AR037407A1 (es) Composiciones farmaceuticas para el tratamiento de la diabetes mellitus de tipo ii
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
PH15562A (en) New hydroxyethyl-azole compounds,their production and their medicinal use
ECSP055528A (es) Composicion farmaceutica que tiene una distribución y potencia uniforme de farmaco
ES2180845T3 (es) Composiciones de silicona dispersables.
PH16119A (en) New hydroxypropyl-triazole compound,their composition and medicinal use
PL1758860T3 (pl) Nasycone i nienasycone 3-pirydylobenzocykloalkilometylo-aminy do leczenia bólów, depresji i stanów lękowych
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
CR7271A (es) Formulaciones farmaceuticas novedosas a base de melatonina y compuestos similares para su uso en transtornos del sueno
JPS5426336A (en) Makeup base composition
AR022017A1 (es) Un agente para tratar el trastorno de la funcion de las celulas visuales. el metodo de tratamiento y el uso de dicho agente para la produccion de unacomposicion farmaceutica
BR0214126A (pt) Composiçáo farmacêutica para interferir na transmissão neuronal, preparação para o rejuvenescimento facial, e, métodos para interferir na transmissão neuronal, e na contração muscular
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
MXPA02010828A (es) Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
AR028987A1 (es) Compuesto derivado de ciclopentapiridin-cetona, composicion farmaceutica que lo contiene y su uso en la fabricacion de un medicamento util para tratar una enfermedad
BR0009194A (pt) Composição do resorcinol